MAZE - Company ID 0001842295
Maze Therapeutics, Inc. has filed 161 public company documents between 2024 and 2026. The most frequent type is insider trade (52 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 1mo ago2026-05-27 | 2026-05-22 | View filing |
| 8-K | Major company event | 1mo ago2026-05-22 | 2026-05-18 | View filing |
| 4 | Insider trade | 1mo ago2026-05-18 | 2026-05-14 | View filing |
| 4 | Insider trade | 1mo ago2026-05-18 | 2026-05-15 | View filing |
| 144 | Insider sale notice | 1mo ago2026-05-15 | - | View filing |
| EFFECT | EFFECT | 1mo ago2026-05-13 | - | View filing |
| 10-Q | Quarterly report | 1mo ago2026-05-12 | 2026-03-31 | View filing |
| 8-K | Major company event | 1mo ago2026-05-12 | 2026-05-12 | View filing |
| POS AM | POS AM | 1mo ago2026-05-12 | - | View filing |
| 4 | Insider trade | 2mo ago2026-05-06 | 2026-05-04 | View filing |
| 4 | Insider trade | 2mo ago2026-05-06 | 2026-05-04 | View filing |
| 4 | Insider trade | 2mo ago2026-05-01 | 2026-04-29 | View filing |
| ARS | Annual report to shareholders | 2mo ago2026-04-28 | 2025-12-31 | View filing |
| DEFA14A | Proxy materials | 2mo ago2026-04-28 | - | View filing |
| DEF 14A | Proxy statement | 2mo ago2026-04-28 | 2026-06-08 | View filing |
| 8-K | Major company event | 2mo ago2026-04-22 | 2026-04-21 | View filing |
| 424B5 | Prospectus supplement | 2mo ago2026-04-22 | - | View filing |
| 4 | Insider trade | 3mo ago2026-04-02 | 2026-04-01 | View filing |
| 4 | Insider trade | 3mo ago2026-04-02 | 2026-04-01 | View filing |
| 4 | Insider trade | 3mo ago2026-04-01 | 2026-03-30 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 3mo ago2026-04-01 | - | View filing |
| 4 | Insider trade | 3mo ago2026-03-31 | 2026-03-27 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-31 | 2026-03-27 | View filing |
| 144 | Insider sale notice | 3mo ago2026-03-30 | - | View filing |
| 10-K | Annual report | 3mo ago2026-03-25 | 2025-12-31 | View filing |
| 8-K | Major company event | 3mo ago2026-03-25 | 2026-03-24 | View filing |
| 4 | Insider trade | 3mo ago2026-03-20 | 2026-03-20 | View filing |
| 4 | Insider trade | 3mo ago2026-03-12 | 2026-03-10 | View filing |
| 144 | Insider sale notice | 4mo ago2026-03-10 | - | View filing |
| 4 | Insider trade | 4mo ago2026-03-03 | 2026-03-02 | View filing |
| 4 | Insider trade | 4mo ago2026-03-03 | 2026-03-02 | View filing |
| 4 | Insider trade | 4mo ago2026-03-03 | 2026-02-27 | View filing |
| 4 | Insider trade | 4mo ago2026-03-03 | 2026-03-02 | View filing |
| 4 | Insider trade | 4mo ago2026-03-03 | 2026-03-02 | View filing |
| 4 | Insider trade | 4mo ago2026-03-03 | 2026-03-02 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 4mo ago2026-02-13 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 4mo ago2026-02-13 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 5mo ago2026-02-06 | - | View filing |
| 4 | Insider trade | 5mo ago2026-02-04 | 2026-02-02 | View filing |
| 4 | Insider trade | 5mo ago2026-02-04 | 2026-02-02 | View filing |
| S-8 | Employee stock plan | 5mo ago2026-02-04 | - | View filing |
| S-3ASR | S-3ASR | 5mo ago2026-02-04 | - | View filing |
| 8-K | Major company event | 5mo ago2026-02-04 | 2026-02-02 | View filing |
| 4 | Insider trade | 5mo ago2026-02-02 | 2026-01-29 | View filing |
| 4 | Insider trade | 5mo ago2026-01-26 | 2026-01-22 | View filing |
| 144 | Insider sale notice | 5mo ago2026-01-16 | - | View filing |
| 4 | Insider trade | 6mo ago2026-01-09 | 2026-01-07 | View filing |
| 4 | Insider trade | 6mo ago2026-01-08 | 2026-01-06 | View filing |
| 144 | Insider sale notice | 6mo ago2026-01-07 | - | View filing |
| 4 | Insider trade | 6mo ago2026-01-06 | 2026-01-02 | View filing |